Atria Investments Inc Sells 5,466 Shares of MetLife, Inc. (NYSE:MET)

Atria Investments Inc reduced its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 12.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 38,857 shares of the financial services provider's stock after selling 5,466 shares during the quarter. Atria Investments Inc's holdings in MetLife were worth $3,182,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp raised its holdings in MetLife by 109.2% in the 4th quarter. Bank of New York Mellon Corp now owns 8,826,658 shares of the financial services provider's stock worth $722,727,000 after purchasing an additional 4,606,748 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in MetLife by 1.5% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider's stock worth $375,179,000 after purchasing an additional 68,579 shares in the last quarter. Nordea Investment Management AB raised its holdings in MetLife by 16.8% in the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider's stock worth $347,735,000 after purchasing an additional 608,224 shares in the last quarter. Charles Schwab Investment Management Inc. raised its holdings in MetLife by 0.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,913,408 shares of the financial services provider's stock worth $320,430,000 after purchasing an additional 30,187 shares in the last quarter. Finally, Swedbank AB raised its holdings in MetLife by 76.0% in the 4th quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider's stock worth $283,862,000 after purchasing an additional 1,496,645 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.

Remove Ads

MetLife Stock Performance

MET traded up $0.06 during midday trading on Friday, hitting $82.28. 3,131,884 shares of the company traded hands, compared to its average volume of 3,554,516. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The firm has a market capitalization of $56.05 billion, a PE ratio of 13.78, a price-to-earnings-growth ratio of 0.65 and a beta of 1.04. The company's 50-day moving average is $83.72 and its 200 day moving average is $82.28. MetLife, Inc. has a 52 week low of $67.30 and a 52 week high of $89.05.

MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. On average, research analysts expect that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be paid a $0.545 dividend. This represents a $2.18 annualized dividend and a dividend yield of 2.65%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife's dividend payout ratio (DPR) is presently 36.52%.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Barclays decreased their price objective on shares of MetLife from $96.00 to $95.00 and set an "overweight" rating for the company in a report on Friday, February 7th. Morgan Stanley increased their price objective on shares of MetLife from $101.00 to $109.00 and gave the company an "overweight" rating in a research report on Friday, February 28th. JPMorgan Chase & Co. increased their price objective on shares of MetLife from $86.00 to $88.00 and gave the company an "overweight" rating in a research report on Tuesday, January 7th. BMO Capital Markets began coverage on shares of MetLife in a research report on Thursday, January 23rd. They set a "market perform" rating and a $97.00 price objective on the stock. Finally, TD Cowen increased their price objective on shares of MetLife from $97.00 to $99.00 and gave the company a "buy" rating in a research report on Wednesday, November 27th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $94.58.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.